FDA Awards Priority Review Voucher to Sponsor of Rare Pediatric Disease Product BYLVAY

Summary

The FDA has issued a priority review voucher to Albireo AB, the manufacturer of BYLVAY, a rare pediatric disease product, following a review of its application under the Federal Food, Drug, and Cosmetic Act.